Anti-inflammatory Effects of Statins in Lung Vascular Pathology: From Basic Science to Clinical Trials.

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1007/978-3-030-63046-1_3PMID 33788186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary Endothelial Mechanical Sensing and Signaling, a Story of Focal Adhesions and Integrins in Ventilator Induced Lung Injury

  2019cited by this paper
• Targeted treatment of acute respiratory distress syndrome with statins-a commentary on two phenotype stratified re-analysis of randomized controlled trials.

  2019cited by this paper
• Statins and Histone Deacetylase Inhibitors Affect Lamin A/C – Histone Deacetylase 2 Interaction in Human Cells

  2019cited by this paper
• Phenotypes in acute respiratory distress syndrome: moving towards precision medicine

  2019cited by this paper
• Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data

  2018cited by this paper
• Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.

  2018cited by this paper
• Safety, Tolerability, and Pharmacokinetics of NK-104-NP.

  2018cited by this paper
• RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis

  2018cited by this paper
• Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats.

  2018cited by this paper
• Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study

  2018cited by this paper
• Statin therapy improves survival in patients with severe pulmonary hypertension: a propensity score matching study

  2017cited by this paper
• Sirt1 Inhibits Oxidative Stress in Vascular Endothelial Cells

  2017cited by this paper
• Are statins beneficial for the treatment of pulmonary hypertension?

  2017cited by this paper
• Simvastatin Ameliorates PAK4 Inhibitor-Induced Gut and Lung Injury

  2017cited by this paper
• Simvastatin Attenuates Acute Lung Injury via Regulating CDC42-PAK4 and Endothelial Microparticles

  2017cited by this paper
• The Effects of Statins on Pulmonary Artery Pressure in Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial

  2017cited by this paper
• Pleiotropic and Adverse Effects of Statins—Do Epigenetics Play a Role?

  2017cited by this paper
• Fifty Years of Research in ARDS. Respiratory Mechanics in Acute Respiratory Distress Syndrome

  2017cited by this paper
• Variability in statin-induced changes in gene expression profiles of pancreatic cancer

  2017cited by this paper
• Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE −/− Mice

  2016cited by this paper
• A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension

  2016cited by this paper
• Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor

  2016cited by this paper
• One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial

  2016cited by this paper
• Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy

  2016cited by this paper
• Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study

  2015cited by this paper
• Lovastatin blocks Kv1.3 channel in human T cells: a new mechanism to explain its immunomodulatory properties

  2015cited by this paper
• Smooth muscle cell progenitors are primed to muscularize in pulmonary hypertension

  2015cited by this paper
• Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications.

  2015cited by this paper
• Role of Integrin β4 in Lung Endothelial Cell Inflammatory Responses to Mechanical Stress

  2015cited by this paper
• Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells

  2015cited by this paper
• Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational study

  2014cited by this paper
• Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer

  2014cited by this paper
• Preoperative Statin Administration Does Not Protect Against Early Postoperative Acute Respiratory Distress Syndrome: A Retrospective Cohort Study

  2014cited by this paper
• Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.

  2014cited by this paper
• Pattern recognition in ARDS: a crucial first step toward personalised treatment.

  2014cited by this paper
• Rosuvastatin for sepsis-associated acute respiratory distress syndrome.

  2014cited by this paper
• Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

  2014cited by this paper
• Simvastatin in the acute respiratory distress syndrome.

  2014cited by this paper
• Evaluation of the Effects of Atorvastatin on the Treatment of Secondary Pulmonary Hypertension due to Chronic Obstructive Pulmonary Diseases: A Randomized Controlled Trial

  2013cited by this paper
• Rho-kinase inhibitor Y-27632 attenuates pulmonary hypertension in hyperoxia-exposed newborn rats

  2013cited by this paper
• Simvastatin treatment inhibits hypoxia inducible factor 1-alpha-(HIF-1alpha)-prolyl-4-hydroxylase 3 (PHD-3) and increases angiogenesis after myocardial infarction in streptozotocin-induced diabetic rat.

  2013cited by this paper
• Caspase functions in cell death and disease.

  2013cited by this paper
• Statins and autoimmunity

  2013cited by this paper
• Atorvastatin in Pulmonary Arterial Hypertension (APATH) study

  2012cited by this paper
• A statin-regulated microRNA represses human c-Myc expression and function

  2012cited by this paper
• Maternal age at childbirth is associated with changes in smoking status between late adolescence and early middle age : results from 22 years of follow-up

  2012cited by this paper
• Critical role for integrin-β4 in the attenuation of murine acute lung injury by simvastatin.

  2012cited by this paper
• Statin therapy as prevention against development of acute respiratory distress syndrome: An observational study*

  2012cited by this paper
• Statin-associated rhabdomyolysis: is there a dose-response relationship?

  2011cited by this paper
• Nanoparticle-Mediated Delivery of Pitavastatin Into Lungs Ameliorates the Development and Induces Regression of Monocrotaline-Induced Pulmonary Artery Hypertension

  2011cited by this paper
• The Pharmacology of Acute Lung Injury in Sepsis

  2011cited by this paper
• Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial Hypertension: ASA-STAT

  2011cited by this paper
• Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study

  2011cited by this paper
• Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome*

  2011cited by this paper
• What is a relevant statin concentration in cell experiments claiming pleiotropic effects?

  2011cited by this paper
• Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension

  2011cited by this paper
• A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study).

  2011cited by this paper
• Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell ‘stemness’ via the bone morphogenetic protein pathway

  2011cited by this paper
• Statin Therapy is Associated with Decreased Pulmonary Vascular Pressures in Severe COPD

  2011cited by this paper
• Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor‐β signal transduction

  2010cited by this paper
• Simvastatin as a treatment for pulmonary hypertension trial.

  2010cited by this paper
• Induction of Endothelial Nitric Oxide Synthase, SIRT1, and Catalase by Statins Inhibits Endothelial Senescence Through the Akt Pathway

  2010cited by this paper
• Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension.

  2009cited by this paper
• Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers.

  2009cited by this paper
• Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.

  2009cited by this paper
• Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract

  2009cited by this paper
• Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury

  2009cited by this paper
• Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes

  2008cited by this paper
• Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition.

  2008cited by this paper
• Simvastatin Stimulates Vascular Endothelial Growth Factor Production by Hypoxia-inducible Factor-1α Upregulation in Endothelial Cells

  2008cited by this paper
• Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.

  2008cited by this paper
• Rosuvastatin and vascular dysfunction markers in pulmonary arterial hypertension: a placebo-controlled study.

  2008cited by this paper
• Statin treatment for rheumatoid arthritis: a promising novel indication

  2008cited by this paper
• Sustained Endothelial Progenitor Cell Dysfunction After Chronic Hypoxia‐Induced Pulmonary Hypertension

  2008cited by this paper
• Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair.

  2008cited by this paper
• Acute Vasodilator Effect of Fasudil, a Rho-kinase Inhibitor, in Monocrotaline-Induced Pulmonary Hypertension in Rats

  2007cited by this paper
• Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway.

  2007cited by this paper
• Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells.

  2006cited by this paper
• Simvastatin treatment of pulmonary hypertension: an observational case series.

  2005cited by this paper
• Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension

  2005cited by this paper
• Statins for atherosclerosis--as good as it gets?

  2005cited by this paper
• Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury.

  2005cited by this paper
• Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs.

  2005cited by this paper
• Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?

  2004cited by this paper
• Atorvastatin Inhibits Autoreactive B Cell Activation and Delays Lupus Development in New Zealand Black/White F1 Mice1

  2004cited by this paper
• Statin use and cancer risk in the General Practice Research Database

  2004cited by this paper
• HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells

  2003cited by this paper
• Lovastatin inhibits brain endothelial cell Rho‐mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis

  2003cited by this paper
• All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells.

  2003cited by this paper
• Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells

  2002cited by this paper
• Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension.

  2002cited by this paper
• DNA methylation patterns and epigenetic memory.

  2002cited by this paper
• A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.

  2001cited by this paper
• Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques: Implications for Plaque Stabilization

  2001cited by this paper
• Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.

  2001cited by this paper
• The metastatic odyssey: the integrin connection.

  2001cited by this paper
• The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9)

  2000cited by this paper
• Statins and the risk of dementia.

  2000cited by this paper
• The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling.

  2000cited by this paper
• Angiogenesis Activators and Inhibitors Differentially Regulate Caveolin-1 Expression and Caveolae Formation in Vascular Endothelial Cells

  1999cited by this paper

• Nanoparticle-driven drug delivery system for cardiovascular treatment.

  2025cites this paper
• Advances in the potential of nebulized inhalation for the treatment of pulmonary arterial hypertension.

  2024cites this paper
• Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma

  2022influential citation
• Localized network hyperconnectivity leads to hyperexcitability after injury

  2022cites this paper
• Novel and robust treatment of pulmonary hypertension with netrin-1 and netrin-1-derived small peptides

  2022cites this paper
• The Putative Role of mTOR Inhibitors in Non-tuberous Sclerosis Complex-Related Epilepsy

  2021cites this paper
• New pharmacological treatments for heart failure with reduced ejection fraction (HFrEF)

  2020cites this paper